Stem Cell Cord Blood 'Banking' Is Huge Global Business for Hospitals, Says CEO of...

Stem Cell Cord Blood 'Banking' Is Huge Global Business for Hospitals, Says CEO
of Bio-Matrix Scientific Group Inc.

SAN DIEGO, July 10 /PRNewswire-FirstCall/ -- David Koos, Chairman and CEO of
San Diego-based Bio-Matrix Scientific Group Inc. (OTC Bulletin Board: BMSN),
today said that he believes that stem cell cord blood banking is a "huge
business opportunity for hospitals worldwide." The Bio-Matrix CEO stated that
hospitals throughout the world are now eagerly starting their own stem cell
cord blood banks. "Hospitals from the U.S. to India are naturally interested
in providing cord blood banking facilities to their patients and the overall
awareness of this stem cell storage banking concept is catching on fast."
Bio-Matrix recently announced a new company marketing program aimed
specifically at hospitals and research centers interested in using its 15,000
square foot stem cell storage bank facility in San Diego.

According to Koos, "Companies like Bio-Matrix are making use of a ready-made
patient customer base by linking up with hospitals, medical institutes,
research institutions and biotechnology companies to assist in stem cell
research and treatments. For hospitals, this kind of marketing partnership is
synergistic at its roots because hospitals would promote cord blood storage
banks leading to additional revenue from every newborn baby delivered. Many
hospitals are starting this kind of cord blood business as part of their
gynecological services because it's a natural extension of the basic service
hospitals provide already and is a cash-rich add on as well."

Koos said that BMSN intends to expand its own marketing program to include
stem cell therapy centers. "We are looking for strategic alliances with
hospitals and research centers on a global level. The Company believes it can
assist these medical institutions in better educating parents about cord blood
banking. We are also in the midst of identifying regional and local partners
whom we can work with."

About Bio-Matrix Scientific Group

Bio-Matrix Scientific Group Inc. (OTCBB: BMSN) is a biotech research and
development company headquartered in San Diego, Ca. with a 15,000 sq. ft.
facility that houses two secure cryogenic stem cell banks, three research
laboratories, aseptic cellular/tissue class 10,000/100 processing lab,
hematology, microbiology and flow cytometry laboratories.

Disclaimer

This news release may contain forward-looking statements. Forward-looking
statements are inherently subject to risks and uncertainties, some of which
cannot be predicted or quantified. Future events and actual results could
differ materially from those set forth in, contemplated by, or underlying the
forward-looking statements. The risks and uncertainties to which
forward-looking statements are subject include, but are not limited to, the
effect of government regulation, competition and other material risks.

www.BMSN.us

SOURCE Bio-Matrix Scientific Group Inc.

David R. Koos, Chairman & CEO of BMSN, +1-619-702-1404, fax, +1-619-330-2328,
info@BMSN.us